{"name":"AlzeCure Pharma","slug":"alzecure-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ACD856","genericName":"ACD856","slug":"acd856","indication":"Other","status":"phase_1"},{"name":"ACD440","genericName":"ACD440","slug":"acd440","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ACD856","genericName":"ACD856","slug":"acd856","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ACD440","genericName":"ACD440","slug":"acd440","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQSWZkcGlycEk4MTRKQzExMHZLb0ppY2JXZGxzQlNmV2pyRU9pMkpFVjVmbm5LcDhoRk15NkE3OEJUalFydVpCVFpuRHpmQl9kX1BQcFZzbWZpbTVjc1l3cXg0ZmtxbVFsemthWHNpLU9WQi1DQVlTYUQ0a0p0dDlaa0J6ODJ6QVJqOXJ1V29NM0RScllkVGs1Q3lnRWpScjRXdjFrd0JzWlAtUTRX?oc=5","date":"2026-04-08","type":"pipeline","source":"Yahoo Finance","summary":"AlzeCure Pharma Publishes its Annual Report for 2025 - Yahoo Finance","headline":"AlzeCure Pharma Publishes its Annual Report for 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQdk1mTEtOMVNjcUlQamdiZTlxQXFySXpJaDZ2bnZaT1ZLWndDVHNSLV9EZjF4MjNTamZOZndLX0Q0RlROLTFQUURtWnZld2FPb25wWmFXeG5sWjhPY1NiSHFSeGg3MVNmRU01TDYwQ3FYZ0xESll1VUFqNmVnLTBvV2czVmM0cWtKUGxvakEyS3hmMm1zbWQ2bzNHdWhZLWZHVVo0VzhsQmUyN3l4bGc?oc=5","date":"2026-03-19","type":"trial","source":"PharmaTimes","summary":"Alzecure shares new preclinical data on NeuroRestore ACD856 at AD/PD conference - PharmaTimes","headline":"Alzecure shares new preclinical data on NeuroRestore ACD856 at AD/PD conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOY0V2aEFXNUlzWmNkdGFnbzhodVhZRFdsUktnS0t5OXh6RFNrbnpMWVNGQzEtUlYybVQtSGRiaG4tdFNoN1Y1SEtHaWc3Mmt3SWI4MDNfbzFNSmtFN2pBaUdjR2tEZzVtb2d4dE00NWszWktnV1NCV0hRamM4NW5yRWJCUGJ2bVpwbDR0WTFXaG5ILTBKanpHTTZDOTZLeTZqSjU3V1FmVDRuNGYzemhKempZcWJ0WEJOSG9ONEJySEpuZzFiNnlqVjlNZFppd0dOOWJpUlVERU9ITWRtSXJ0UENHSHM2RlU?oc=5","date":"2026-03-19","type":"trial","source":"marketscreener.com","summary":"AlzeCure Pharma AB Presents New Preclinical Data with NeuroRestore ACD856 at Alzheimer?s Conference AD/PD - marketscreener.com","headline":"AlzeCure Pharma AB Presents New Preclinical Data with NeuroRestore ACD856 at Alzheimer?s Conference AD/PD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxOQm9hQ2xZVUJjRjB0X2tCTFlUeS1SSDlNWnE1eFdhSzBIa1p6VnBaQktydkVxQUlxLXVJU3BPZkxNRFcwa3BKTG5hcTJUUG5jNzJLNVpncURQd3kzZ3phczhuOC1qT0Q1UlIzR2RycVZUX0hvc3RlaE9MeEs1azd6ZGtLZGdiYWlpNEFoSktTOTI1Zw?oc=5","date":"2026-03-04","type":"pipeline","source":"Yahoo Finance","summary":"AlzeCure Pharma to Present at Stora Aktiedagarna in Stockholm on March 11 - Yahoo Finance","headline":"AlzeCure Pharma to Present at Stora Aktiedagarna in Stockholm on March 11","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE02TUxjTXBVbFBkWGtJZ1ExMjJCMnEydWJDdkRmb3dYTC1DUDM2ekFhV2FNNm9WSkxvQVRsRDJyT05RSFJDRV9VMTFyZGdSZXJaanZQekdFYk0tSzVfUHdOS0ozdFBBaWR5S2hlRFpoN0hvSFd0VThCU1JBdEFMdw?oc=5","date":"2026-02-24","type":"pipeline","source":"PharmaTimes","summary":"ACD440 granted orphan drug status in the EU - PharmaTimes","headline":"ACD440 granted orphan drug status in the EU","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxQdWpGM3R2V0pmVnozODNCbXIwSWpKZGFFMEx3Tm4xSlpMUng1VXkyOXhKRlhZMS0xTEpjXy1jcDFkd1Nya1ZTb3JxbzF1eVpOdkV5M2ZKejFRcDJqVmtzOTBtSW9pQjZKWmluaUFhVzYxVUsxRVNUalRGSEVIbDFmaVB3SGZQVUxmLVJFblVNajJTd2dtcUVxNjgyVi0tMWdyenFqVnkwdVNGSTVxZFc0LXB1Wk1YdG9UX2ZFYTBzUWN4VkJEVEFRbDJnOFZpRTkyWGU2cEFtcXQ1bHBwbWxJTnJ4WXI?oc=5","date":"2026-02-02","type":"pipeline","source":"ACCESS Newswire","summary":"AlzeCure Pharma Selected to Present at the Bio-Neuroscience conference in Amsterdam - ACCESS Newswire","headline":"AlzeCure Pharma Selected to Present at the Bio-Neuroscience conference in Amsterdam","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQX1d0SGFzVEl5ODRGeXY2ZWMzQXhqS3NDTU5WaXVmV3BubHFnQjVHd0dLSFZ1aXpqdG9qX1V3OHpscHRUQXhsdzRZb203bWY5OWVzOGVfa0UtMlZhUXlQWnZyazVLMkZjcUVwV0FYMXZKV2FjYU1DYmhQODVKX1pnRFViOVRfRmVr?oc=5","date":"2025-12-03","type":"trial","source":"PharmaTimes","summary":"AlzeCure secures EU grant for Alzheimer’s drug trial - PharmaTimes","headline":"AlzeCure secures EU grant for Alzheimer’s drug trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNUE9SZzN4T05hRnk4N0lEeTB2RkhVOHJFX3Rra1N0MUNWeDF3M20zakJ1TXN4TDNDbGZzNC1QTHF2RmFJUjRxdzFRa2FBc1h5TzNCSmwzbHF1NExiYWUzRUZYQkgzM1BCQ2FsS2dGYVUyY3BJME84dmFjVTN2YVhiYi1uTHBYT3pqTFNfRkRBVQ?oc=5","date":"2025-09-04","type":"trial","source":"PharmaTimes","summary":"AlzeCure presents phase 2 data on ACD440 at NeuPSIG 2025 - PharmaTimes","headline":"AlzeCure presents phase 2 data on ACD440 at NeuPSIG 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQSWUtR19PNXNGUWxoN3pIR3RhcW1TdUk3dDVtZWE2cVVfZkRhNW1TX0FPZEVJdW1OdmdFcHl0dG54Y2ZtVU83amUyQ2ctajhlN01pclNBYWtGYzVTMlhZNDh2QWdRZTNZU0dXaFdUQlRfczV2UENiSC1xcXhOSVdCSzZKWGNXM01PS3h6bzJieGJZc3hqeWQ5WWRIbw?oc=5","date":"2025-07-21","type":"pipeline","source":"PharmaTimes","summary":"AlzeCure to present promising pain therapy ACD440 at NeuPSIG 2025 - PharmaTimes","headline":"AlzeCure to present promising pain therapy ACD440 at NeuPSIG 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNMVFxSFlOTmJodWZUY0lUQWw4LURFUWtsRlFHS0oxc2pncTkydy0xMS1ocm1IazNaZnQ2OVlwQmpjMEk2MXd4czVQVk1wUk1zT3hOa2ExS1BPeTh0aElFQW1QbUo0blk0V01JUHpSemsyVG4xT0RjbkdZbzM5RzZpalVjRWpLaGh3X0FBanF2dllFQ2RZbDZfM2xZbkFQSElQVXppSlJOQUxiM0stdEhWUFA0YkdmaWNadUZPQnlB?oc=5","date":"2025-02-18","type":"trial","source":"Clinical Trials Arena","summary":"AlzeCure Pharma secures €2.5m grant for Phase IIa trial of Alzheimer’s treatment - Clinical Trials Arena","headline":"AlzeCure Pharma secures €2.5m grant for Phase IIa trial of Alzheimer’s treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxOR2hGUXVCMTZjcnAwRkNuZGxSLU9uOEUzNjFEcnR3ZVk0cjBSbmpvVTVVSFFXN2lmcjFfWWlyN0R2TDA5U0ZLVk5FZWRHTkpEMkRNTXdiRXdwd0tVbTZHbzduT3hxalB1cGNKbmR3U3RCZndvWFNoaUd2bUFzTDNKNUxxVmJIdw?oc=5","date":"2023-05-23","type":"patent","source":"Pharmaceutical Technology","summary":"AlzeCure Pharma’s ACD856 receives European patent - Pharmaceutical Technology","headline":"AlzeCure Pharma’s ACD856 receives European patent","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOQXlDOTI3Yllpa3RtbW0yam4wYkJsSVhyN050WWQ3X2EwSEZmcHBmdm5ldnhNSDc5cGdYSjZGZ19UZzhlSHNWS0RCSTNCTlpjZ3JIWG5jdDFLamVrdmlvWFhDSVNtZjZjelFycGxrejFPb0ZKVVZSRW5yNGdrWm9LbUlDUVVqc2JvaWRmZ1JR?oc=5","date":"2022-12-13","type":"pipeline","source":"Yahoo Finance UK","summary":"AlzeCure Pharma AB's Chief Scientific Officer has Participated in an Interview with Erik Penser Bank - Yahoo Finance UK","headline":"AlzeCure Pharma AB's Chief Scientific Officer has Participated in an Interview with Erik Penser Bank","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}